North America Medical Marijuana Market Share and Key Trends by 2028 Regional
Analysis, Key Players

The North
America medical marijuana market is expected to grow from US$ 7,170.17
million in 2022 to US$ 20,760.41 million by 2028. It is estimated to register a
CAGR of 19.4% from 2022 to 2028.   

The increasing acceptance and regulatory approvals of
medical marijuana products are significant drivers fueling the growth of the North
America medical marijuana market. Researchers and companies are actively
exploring the therapeutic potential of cannabis, with tetrahydrocannabinol
(THC) being a key component in many medicinal applications.

For instance, the US Food and Drug Administration (FDA) has
approved several THC-based drugs. Cesamet, containing the synthetic cannabinoid
nabilone, is prescribed to manage chemotherapy-induced nausea and vomiting when
other treatments prove ineffective. Marinol and Syndros, both containing
synthetic 9-THC (dronabinol), are approved to stimulate appetite in patients
with AIDS-related wasting syndrome. The pipeline for marijuana-based
therapeutics is also active, with products like nabiximols (Sativex), already
approved in Canada, being used to treat spasticity and neuropathic pain
associated with multiple sclerosis. Nabiximols combines THC with cannabidiol
(CBD). Furthermore, Canadian companies like CanaQuest Medical Corp are seeking
approval for new THC-based products like Mentabinol under Canada's Cannabis
Act. These increasing approvals from regulatory bodies like the FDA are a major
catalyst for the medical marijuana market's expansion.

North America Medical Marijuana Market Overview

The North America medical marijuana market encompasses the
US, Canada, and Mexico, with the US currently holding the largest market share.
This growth is driven by several factors, including increasing research and
collaborations focused on novel therapeutic applications of cannabis, growing
public awareness regarding its medical benefits, and the presence of key
industry players in the region. Additionally, the expanding aging population
across North America is expected to further contribute to market growth.

North America Medical Marijuana Strategic Insights

Strategic insights for the North America medical marijuana
market offer a data-driven analysis of the industry's current landscape,
highlighting key trends, major players, and regional variations. These insights
provide actionable recommendations that can help stakeholders differentiate
themselves by identifying underserved market segments or developing unique
value propositions. By leveraging data analytics, industry players can
anticipate market shifts, whether they are investors, manufacturers, or other
stakeholders. Adopting a future-oriented perspective is crucial for long-term
success in this dynamic region, enabling stakeholders to proactively position
themselves for market changes and make informed decisions that drive
profitability and achieve their business objectives.

North America Medical Marijuana Regional Insights

The geographic scope of the North America medical marijuana
market

defines the specific areas in which businesses operate and
compete. Understanding local nuances, such as differing consumer preferences
(for example, the demand for specific product formats or delivery methods),
varying economic conditions, and diverse regulatory environments, is essential
for tailoring market strategies. Businesses can expand their market reach by
identifying underserved areas or adapting their product offerings to meet local
demands. A focused market approach allows for more effective resource
allocation, targeted marketing campaigns, and improved positioning against
local competitors, ultimately fostering growth within those specific areas.

North America medical marijuana market Segments Covered

North America medical marijuana market By Product Type

• Dried
  Form


• Extract
  Form

North America medical marijuana market By Application

• Pain
  Management


• Tourette's


• Alzheimer's
  Disease


• Migraines


• Depression
  and Anxiety


• Multiple
  Sclerosis


• Cancer

North America medical marijuana market By Distribution
Channel

• Retail
  Pharmacy


• E-Commerce

North America medical marijuana market Regions and
Countries Covered

North America

• US


• Canada


• Mexico

North America medical marijuana market leaders and key
company profiles

• Aphria,
  Inc.


• CanaQuest
  Medical Corporation


• Canopy
  Growth Corporation


• Emerald
  Health Therapeutics Inc.


• GW
  Pharmaceuticals


• MARICANN
  INC.


• Organigram
  Holdings Inc.


• Panaxia
  Pharmaceutical Industries Ltd.


• Phoena
  Holdings Inc.


• VIVO
  Cannabis Inc

Other Reports:

North America Gummy Supplements Market: https://penzu.com/p/8503c42ca09ae4f7 

North America Radiation-Hardened Electronics Market: https://github.com/SuryakantGadekar/Business-Market-Insights/issues/26 

North America mHealth Market: https://sites.google.com/view/n-mhealth-market/home 

North America Synthetic Biology Market: https://business-news-insights.blogspot.com/2025/05/north-america-synthetic-biology-market.html 
 

About Us:

Business Market Insights is a market research platform
that provides subscription service for industry and company reports. Our
research team has extensive professional expertise in domains such as
Electronics & Semiconductor; Aerospace & Defense; Automotive &
Transportation; Energy & Power; Healthcare; Manufacturing &
Construction; Food & Beverages; Chemicals & Materials; and Technology,
Media, & Telecommunications.

Author’s Bio:

Suryakant Gadekar

Senior Market Research Expert at Business Market
Insights